VIM-AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma
2024

Hypermethylation drives aggressiveness in liver cancer

publication 10 minutes Evidence: high

Author Information

Author(s): Han Su-hyang, Ko Je Yeong, Jung Sungju, Oh Sumin, Kim Do Yeon, Kang Eunseo, Kim Myung Sup, Chun Kyung-Hee, Yoo Kyung Hyun, Park Jong Hoon

Primary Institution: Sookmyung Women’s University

Hypothesis

The study aims to identify DNA methylation markers related to the prognostic outcomes of hepatocellular carcinoma (HCC) and to examine the regulation of long noncoding RNAs through methylation.

Conclusion

The downregulation of VIM-AS1 due to hypermethylation at cg02746869 increases EPHA3 mRNA expression via a m6A-dependent mechanism, promoting HCC aggressiveness.

Supporting Evidence

  • Hypermethylation of cg02746869 is linked to poor prognosis in liver cancer.
  • VIM-AS1 regulates EPHA3 mRNA stability, which is associated with HCC aggressiveness.
  • Overexpression of VIM-AS1 inhibits the migration and invasion of HCC cells.
  • IGF2BP1 binding to EPHA3 mRNA is crucial for its stability.

Takeaway

Scientists found that a specific change in DNA can make liver cancer cells more aggressive, and they discovered a way to measure this change.

Methodology

The study used DNA methylome data from HCC patient samples and performed RNA sequencing and various assays to analyze gene expression and methylation.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/s12276-024-01352-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication